{"id":528496,"date":"2010-04-15T10:40:48","date_gmt":"2010-04-15T14:40:48","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=73516"},"modified":"2010-04-15T10:40:48","modified_gmt":"2010-04-15T14:40:48","slug":"histogen-sees-hair-raising-results-avalon-ventures-mulls-raising-a-new-fund-atheadx-closes-funding-round-more-san-diego-life-sciences-news","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/528496","title":{"rendered":"Histogen Sees Hair-Raising Results, Avalon Ventures Mulls Raising a New Fund, AtheaDX Closes Funding Round, &amp; More San Diego Life Sciences News"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/Roundup\/\">Roundup<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/health-it\/\">Health IT<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/Venture-Capital\/\">Venture Capital<\/a><\/div>\n<p>\t\t<strong>Denise Gellene wrote:<\/strong><\/p>\n<p>We heard in the past week from key experts who shared their views on the funding climate and the potential of emerging computational technologies. Our recap follows.<\/p>\n<p>&#8212;<strong>Histogen<\/strong> said its Hair Stimulating Complex produced &#8220;statistically significant&#8221; new hair growth after one year among the 24 balding patients who participated in <a href=\"http:\/\/www.xconomy.com\/san-diego\/2010\/04\/14\/histogen-reports-lasting-effects-in-small-study-of-baldness-treatment\/\">a clinical trial <\/a>conducted in Honduras.<\/p>\n<p>&#8212;<strong>Avalon Ventures<\/strong>, one of the few San Diego venture capital firms still investing in early-stage life sciences companies, <a href=\"http:\/\/www.xconomy.com\/san-diego\/2010\/04\/12\/avalon-stakes-claim-as-survivor-among-san-diego-biotech-vcs\/\">is talking about raising a ninth fund<\/a>, Luke reported. He chatted with principals Jay Lichter and Kevin Kinsella about the investing climate.<\/p>\n<p>&#8212;San Diego is well-positioned to play a significant role in advancing computational biology, <a href=\"http:\/\/www.xconomy.com\/san-diego\/2010\/04\/14\/life-sciences-in-san-diego-gets-analytical-a-chat-with-paul-a-rejto-head-of-computational-biology-at-pfizer-oncology\/\">said Paul A. Rejto, director of computational biology in oncology research at Pfizer<\/a>. He discussed the technology and its potential impact on drug development in a Q&amp;A.<\/p>\n<p>&#8212;San Diego has all the ingredients to become the number one biomedical informatics center in the country, <a href=\"http:\/\/www.xconomy.com\/san-diego\/2010\/04\/09\/is-bioinformatics-in-san-diegos-future-a-chat-with-uc-san-diego-expert-lucila-ohno-machado\/\">said UC San Diego&#8217;s Lucila Ohno-Machado<\/a>, director of biomedical informatics at the medical school. She discussed the technology with me in a Q&amp;A.<\/p>\n<p>&#8212;<strong>Amplyx Pharmaceuticals<\/strong>, a San Diego-based drug developer, has <a href=\"http:\/\/www.xconomy.com\/san-diego\/2010\/04\/08\/amplyx-pharma-nabs-1-5m\/\">raised an initial round of $1.5 million <\/a>in financing. The investors included Golden Seeds, Life Science Angels, and Tech Coast Angels.<\/p>\n<p>&#8212;<strong>AltheaDx<\/strong>, a San Diego-based developer of molecular diagnostics, <a href=\"http:\/\/www.xconomy.com\/san-diego\/2010\/04\/14\/altheadx-closes-6m-a-round\/\">closed its $6 million Series A round <\/a>of funding. The funds will support development of diagnostics that predict whether a drug is safe for certain people.<\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/san-diego\/2010\/04\/15\/histogen-sees-hair-raising-results-avalon-ventures-mulls-raising-a-new-fund-atheadx-closes-funding-round-more-san-diego-life-sciences-news\/#comments\">Comments<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20Histogen%20Sees%20Hair-Raising%20Results,%20Avalon%20Ventures%20Mulls%20Raising%20a%20New%20Fund,%20AtheaDX%20Closes...%20http:\/\/xconomy.com\/?p=73516\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/san-diego\/2010\/04\/15\/histogen-sees-hair-raising-results-avalon-ventures-mulls-raising-a-new-fund-atheadx-closes-funding-round-more-san-diego-life-sciences-news\/&#038;t=Histogen%20Sees%20Hair-Raising%20Results,%20Avalon%20Ventures%20Mulls%20Raising%20a%20New%20Fund,%20AtheaDX%20Closes%20Funding%20Round,%20&amp;%20More%20San%20Diego%20Life%20Sciences%20News\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/san-diego\/2010\/04\/15\/histogen-sees-hair-raising-results-avalon-ventures-mulls-raising-a-new-fund-atheadx-closes-funding-round-more-san-diego-life-sciences-news\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=Histogen+Sees+Hair-Raising+Results%2C+Avalon+Ventures+Mulls+Raising+a+New+Fund%2C+AtheaDX+Closes+Funding+Round%2C+%26amp%3B+More+San+Diego+Life+Sciences+News&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fsan-diego%2F2010%2F04%2F15%2Fhistogen-sees-hair-raising-results-avalon-ventures-mulls-raising-a-new-fund-atheadx-closes-funding-round-more-san-diego-life-sciences-news%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>UNDERWRITERS AND PARTNERS<br \/>\n\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 168652\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d1.openx.org\/ck.php?bannerid=168652' ><br \/>\n\t\t\t\t<img src='http:\/\/d1.openx.org\/avw.php?bannerid=168652&amp;cb=73' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 170430\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d1.openx.org\/ck.php?bannerid=170430' ><br \/>\n\t\t\t\t<img src='http:\/\/d1.openx.org\/avw.php?bannerid=170430&amp;cb=754' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 168561\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d1.openx.org\/ck.php?bannerid=168561' ><br \/>\n\t\t\t\t<img src='http:\/\/d1.openx.org\/avw.php?bannerid=168561&amp;cb=495' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 168283\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d1.openx.org\/ck.php?bannerid=168283' ><br \/>\n\t\t\t\t<img src='http:\/\/d1.openx.org\/avw.php?bannerid=168283&amp;cb=361' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 169782\n    [1] => 169781\n    [2] => 326694\n    [3] => 169779\n    [4] => 302914\n    [5] => 169787\n    [6] => 169789\n    [7] => 169790\n    [8] => 169791\n    [9] => 169786\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d1.openx.org\/ck.php?bannerid=169782' ><br \/>\n\t\t\t\t<img src='http:\/\/d1.openx.org\/avw.php?bannerid=169782&amp;cb=120' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 168655\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d1.openx.org\/ck.php?bannerid=168655' ><br \/>\n\t\t\t\t<img src='http:\/\/d1.openx.org\/avw.php?bannerid=168655&amp;cb=420' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t\t<!-- ad options: Array\n(\n    [0] => 356568\n    [1] => 247233\n    [2] => 247233\n)\n1 --><br \/>\n\t\t\t\t<a href='http:\/\/d1.openx.org\/ck.php?bannerid=356568' ><br \/>\n\t\t\t\t<img src='http:\/\/d1.openx.org\/avw.php?bannerid=356568&amp;cb=443' border='0' alt='' \/><\/a><br \/>\n\t\t\t\t\t\t\t\t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=c6f530e1c1fe236514936c6a8caef6d2&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=c6f530e1c1fe236514936c6a8caef6d2&#038;p=1\"\/><\/a><br \/>\n<img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" style=\"display:none\" src=\"http:\/\/ib.adnxs.com\/seg?add=24595&#038;t=2\"\/><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/6sm3jzUN7RJXlZ9Iq_GnV7ZdI28\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/6sm3jzUN7RJXlZ9Iq_GnV7ZdI28\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/6sm3jzUN7RJXlZ9Iq_GnV7ZdI28\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/6sm3jzUN7RJXlZ9Iq_GnV7ZdI28\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/ySQ9SJ3wk1k\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Roundup, Health IT, Venture Capital Denise Gellene wrote: We heard in the past week from key experts who shared their views on the funding climate and the potential of emerging computational technologies. Our recap follows. &#8212;Histogen said its Hair Stimulating Complex produced &#8220;statistically significant&#8221; new hair growth after one year among the 24 balding patients [&hellip;]<\/p>\n","protected":false},"author":2918,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-528496","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/528496","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/2918"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=528496"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/528496\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=528496"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=528496"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=528496"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}